Latest Articles

Article Type

Open Access
Pharmacokinetics and Safety Studies in Rodent Models Support Development of EPICERTIN as a Novel Topical Wound-Healing Biologic for Ulcerative Colitis
Daniel Tusé, Micaela Reeves, Joshua Royal, Krystal T. Hamorsky, Hanna Ng, Maria Arolfo, Carol Green, Abhishek Trigunaite, Toufan Parman, Goo Lee and Nobuyuki Matoba

Journal of Pharmacology and Experimental Therapeutics March 2022, 380 (3) 162-170; DOI: https://doi.org/10.1124/jpet.121.000904
You have access
Correction to “Antinociceptive and Discriminative Stimulus Effects of Six Novel Psychoactive Opioid Substances in Male Rats”
Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 142; DOI: https://doi.org/10.1124/jpet.121.000689err
You have access
Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors
Chitra Saran, Louise Sundqvist, Henry Ho, Jonna Niskanen, Paavo Honkakoski and Kim L. R. Brouwer

Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 114-125; DOI: https://doi.org/10.1124/jpet.121.000828
Open Access
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery
Thuy-Vi V. Nguyen, Rachel H. Crumpacker, Kylie E. Calderon, Frankie G. Garcia, Jacob C. Zbesko, Jennifer B. Frye, Selena Gonzalez, Danielle A. Becktel, Tao Yang, Marco A. Tavera-Garcia, Helena W. Morrison, Rick G. Schnellmann, Frank M. Longo and Kristian P. Doyle

Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 126-141; DOI: https://doi.org/10.1124/jpet.121.000711
You have access
Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs
Irene Vuu, Edward E. Patterson, Chun-Yi Wu, Dorota Zolkowska, Ilo E. Leppik, Michael A. Rogawski, Gregory A. Worrell, Vaclav Kremen, James C. Cloyd and Lisa D. Coles

Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 104-113; DOI: https://doi.org/10.1124/jpet.121.000736
You have access
Evidence for Alpha₇ Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough
Brendan J. Canning, Qi Liu, Mayuko Tao, Robert DeVita, Michael Perelman, Douglas W. Hay, Peter V. Dicpinigaitis and Jing Liang

Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 94-103; DOI: https://doi.org/10.1124/jpet.121.000641
You have access
A Message from the New Editor-in-Chief
Beverley Greenwood-Van Meerveld

Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 92-93; DOI: https://doi.org/10.1124/jpet.121.000984
You have access
A Putative New Melatonin Binding Site in Sheep Brain, MTx: Preliminary Observations and Characteristics
Preety Shabajee-Alibay, Anne Bonnaud, Benoît Malpaux, Philippe Delagrange, Valérie Audinot, Saïd Yous, Jean A. Boutin, Jean-Philippe Stephan, Jérôme Leprince and Céline Legros

Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 76-89; DOI: https://doi.org/10.1124/jpet.121.000785
You have access
Correction to “A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor ɣ with Excellent Effect on Insulin Resistance and Type 2 Diabetes”
Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 90-91; DOI: https://doi.org/10.1124/jpet.115.223107err
Open Access
Protein Kinase A–Mediated Effects of Protein Kinase C Partial Agonist 5-(Hydroxymethyl)Isophthalate 1a3 in Colorectal Cancer Cells
Ilari Tarvainen, Rebecca C. Nunn, Raimo K. Tuominen, Maria H. Jäntti and Virpi Talman

Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 54-62; DOI: https://doi.org/10.1124/jpet.121.000848

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals